Fresh sell signal ranks 2nd among 140 US stocks
Beam Therapeutics drops 15.8% as the rebound gets crushed by sellers
Fresh sell signal ranks 2nd among 140 US stocks
Our view last week
Beam Therapeutics stock drops 6.1% in a week ruled by sellers, with only 19% of volume on the buy side and money flow turning negative after weeks of accumulation. The weekly technical analysis, though, does not retreat: the ADX climbs to 34.5, the trend gaining conviction. The gain since entry stays positive, now down to 4.1%.
This week's summary
Beam Therapeutics stock drops 15.8% in a week ruled by sellers: the rebound attempt collapsed against an extreme wave of selling in the final session, with the stock already deep in a distribution phase. The weekly technical analysis marks it out: a fresh sell signal, ranking second among the 140 US stocks on our sell list. Volatility stays very high: opening a position now, per our model, is high-risk.
IQS Phase
84
in tension / maturity
Signal Strength
100
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#2 / 140
New us stocks
Trade P&L %
+0.00%
from signal to today
restricted Platinum content